Research on new and better ways to treat cancer. Covers radiotherapy, targeted microdroplets, nerve-injury protection, drug combinations, and tumor models.
Researchers at Ohio State University Comprehensive Cancer Center identified microRNA-3151 as a new independent prognostic marker in certain patients with acute leukemia. The study found that overexpression of miR-3151 leads to poor treatment responses and shorter survival periods, independent of other gene mutations.
Researchers at CNIO successfully test first gene therapy to combat aging, extending mouse lifespan up to 24 percent and improving health. The therapy delivers a 'rejuvenating' effect using telomerase enzyme, repairing or delaying DNA damage.
Researchers at Rutgers University have discovered a new way to stimulate the activity of immune cell opiate receptors, leading to efficient tumor cell clearance. The study builds upon previous research showing that replenishing endorphins can prevent stress and immune problems in fetal alcohol-exposed test subjects.
A UNC-led team discovers that lung cancer molecular subtypes correlate with distinct genetic alterations and patient response to therapy. The study refines their previous report on three molecular subtypes of non-small cell lung cancer, suggesting new avenues for targeted treatment.
Scientists at NC State University developed a method to turn gene expression on and off using light-activated molecules. This technique enables precise control over gene function, potentially leading to targeted therapies for diseases like cancer.
A recent study published in the Journal of the National Cancer Institute found that physical activity is associated with reduced mortality in breast and colon cancer patients. The research suggests that exercise may provide benefits such as improved insulin levels, reduced inflammation, and enhanced immunity for cancer survivors.
Heidelberg University Hospital's Breast Center reports excellent treatment results for breast cancer patients in Germany. Eighty-six percent of patients survived the first five years after onset of treatment and 80% remained disease-free during this period.
Researchers identified a genetic pathway that influences the spread of cancer cells, which could lead to new treatment avenues. The study found that changes in genetics affect DNA methylation, causing cells to divide uncontrollably.
A new study finds that differences in screening account for 42% of the observed disparity in colorectal cancer incidence and 19% of disparity in mortality between blacks and whites. Equal access to care could substantially reduce racial disparities in colorectal cancer rates.
Researchers at Joslin Diabetes Center have identified a critical mechanism involving the TOR protein kinase and master gene regulator proteins SKN-1 and DAF-16, which can increase stress resistance and longevity in various species.
Researchers at St. Jude Children's Research Hospital found no significant difference in survival rates between African-American and white children treated for virtually all cancers during a 15-year period. The study suggests equal access to comprehensive treatment translates into equally good outcomes, closing the racial survival gap.
Researchers at Moffitt Cancer Center found that adolescents newly diagnosed with cancer have strong concerns about their ability to have children as cancer survivors. Parents often inaccurately relayed their child's reproductive concerns and underestimated their daughters' desires for future parenthood.
Researchers have found that adding boron-nitride nanotubes to cancer cells can increase the effectiveness of a minimally invasive treatment for soft tissue tumors. The treatment, known as Irreversible Electroporation, has been shown to kill twice as many cancer cells when BNNTs are present on the cell surface.
Girls who start puberty prematurely are at risk of psychological problems, including adolescent behavior issues, and may face increased risks of sexual abuse and early pregnancy. Treatment options, such as hormone therapy, can help manage symptoms and improve outcomes.
A study confirms that prostate cancer screening is widely ignored in men aged 75 or older, defying 2008 guidelines. Nearly half of men in this age group continue to receive screenings, highlighting the need for selective screening.
A Canadian study found opioids significantly improved the quality of life and relief from shortness of breath for advanced COPD patients. However, physicians were hesitant due to lack of guidance, fear of respiratory suppression, and concerns about censure. Innovative educational initiatives may help bridge this gap in care.
Researchers at Bascom Palmer Eye Institute have developed a novel gene therapy to treat Leber Hereditary Optic Neuropathy (LHON), an inherited genetic defect that causes rapid vision loss. The treatment successfully replaces mutated genes with healthy ones, restoring visual function in experimental models.
A team led by Martin Friedlander at Scripps Research Institute has received a $10.2 million grant to develop a new treatment strategy for diabetic retinopathy, macular degeneration, and other vision disorders. The approach targets a strand of micro-RNA that promotes abnormal blood vessel growth.
Researchers found that early treatment can significantly improve outcomes for a rare and often undiagnosed form of encephalitis. The study analyzed 565 cases of Anti-NMDA Receptor Encephalitis and determined that second-line therapy improves outcomes compared to repeating treatments or no additional treatments.
Three large studies from India, China, and the Middle East expose a consistent pattern of inadequate treatment for women with acute coronary syndrome (ACS), resulting in poorer outcomes. Women tend to be admitted later, have more comorbid disease, and receive less aggressive treatment than men.
A Scripps Research Institute scientist has been awarded a $1 million grant to develop new tests for stress-associated diseases, including atherosclerosis, Alzheimer's disease, and Parkinson's disease. The goal is to identify drug leads that can prevent oxidative damage in zebrafish.
A study published in Archives of Otolaryngology – Head & Neck Surgery suggests that targeted swallowing exercises can alleviate debilitating side effects in people undergoing chemoradiation therapy for head and neck cancer. Patients who performed five targeted swallowing exercises throughout their CRT showed significantly better scores...
A study found the diagnostic yield of colonoscopy for melena after a nondiagnostic upper endoscopy to be 4.8 percent, significantly lower than previously reported. The rate of therapeutic intervention was also very low at 1.7 percent, suggesting that most procedures are diagnostic-only and can be performed on an elective basis.
The Prospective Surveillance Model is a novel approach to managing pathological conditions resulting from cancer treatment by promoting early identification and treatment of known side effects. The goal of the model is to identify impairment at the earliest onset, alleviate impairment, or prevent it from progressing.
Researchers identify non-classical oncogenes critical for leukemia cell survival and develop a strategy targeting these molecules, potentially reducing toxicity of current treatments. Dual inhibition of PI3K subtypes supports cancer cell death in mice and human tumor cells.
Performing targeted swallowing exercises following chemoradiation therapy (CRT) for head and neck cancer improves swallowing function in the short term. However, this benefit does not last beyond three months, with no significant difference found at nine or 12 months post-treatment.
A study at Wake Forest Baptist Medical Center found that patients prefer immediate access to radiology test results, even for complex diagnoses. The study showed that about half of participants preferred instant access, while a third preferred access within three days.
A study at Fox Chase Cancer Center found that patients with a specific variant of the CYP1B1 gene have a longer time-to-recurrence of squamous cell carcinoma of the head and neck. This discovery could lead to tailored treatment approaches for affected individuals.
A new mathematical model predicts optimal treatment length for prostate cancer patients to delay resistance, allowing clinicians to tailor therapy effectively. Intermittent androgen suppression therapy reduces side effects and improves patient outcomes.
Researchers have identified a new protein, S100PBP, that suppresses cathepsin Z and reduces pancreatic cancer cells' ability to attach to other tissues. This discovery may lead to the development of novel preventive and therapeutic targets for pancreatic cancer.
Researchers are using pond scum microbes called Euglena to develop a new test for detecting cancer cells in the bloodstream. The test uses the microbe as a natural cargo carrier to identify and analyze circulating tumor cells, which enable cancer to spread.
Researchers have discovered a new mechanism of prostate cancer cell metabolism by identifying the PFKFB4 gene, which is vital for tumor growth and antioxidant production. The study found that depletion of this gene in laboratory models inhibited tumor growth, suggesting potential targeted therapies.
A Dutch study reveals that breast cancer screening and improved treatments together save a significant number of lives. The study found that adjuvant therapy reduced deaths by 13.9%, while two-yearly screening added another 15.7%. Combining both approaches resulted in a total reduction of 31.1% in breast cancer mortality.
Scientists have developed a new method for studying selenium metabolism in living organisms, which could help clarify the element's potential anti-tumor properties. The technique uses enriched stable isotopes to track selenium concentrations in biological tissues and fluids, revealing its presence and behavior in the body.
Researchers found that smoking restored depleted self-control resources in smokers, improving their mood and performance on frustrating tasks. This study suggests that nicotine can be a maladaptive way to cope with stress, and alternative strategies like relaxation or sugary drinks may be healthier options.
A recent study published in Cancer Research suggests that dietary cadmium may be associated with an increased risk of breast cancer. Women who consumed higher amounts of whole grain and vegetables had a lower risk of breast cancer compared to those exposed through other foods.
A new report estimates that broader screening for hepatitis C virus (HCV) would be cost-effective in reducing mortality and morbidity. The study recommends a one-time screening for all adults between 20 and 69 years old to identify those infected with the virus, which affects 4 million U.S. residents.
A new study suggests that broader screening for hepatitis C virus (HCV) would be cost effective in reducing related mortality and morbidity. The report emphasizes the importance of linking those infected with the treatment they need to prevent further complications.
A study by the Trudeau Institute has identified key mechanisms in controlling gamma-herpesvirus infections and their implications for treating and preventing cancer. Researchers found that immune responses differ between initial active phase and long-term latent infection phases.
Children treated for cancer before age 4 experience delays in vocabulary, cognitive functions, and motor skills compared to their healthy peers. However, social and emotional development remains unaffected.
Researchers will focus on inhibiting cancer cell metabolism by targeting Mct1 and Mct4 proteins, which transport lactic acid out of cancer cells. The goal is to develop broad-spectrum anti-cancer therapeutics for breast cancer and lymphoma.
Dr. Kari Alitalo receives the award for his outstanding contributions to lymphatic science and advancement of VEGF-C lymph node transplant research, which shows promise in treating lymphedema and improving lymphatic function.
Chinese Minister of Health Dr. Zhu Chen will hold talks with leading cancer researchers from the US and China to develop a stronger platform for Sino-US research collaboration. The goal is to fast-track cancer research and create deeper ties among researchers.
Researchers found that vitamin D reduced the size of uterine fibroids in laboratory rats by an average of 75% compared to untreated groups. This study provides promising evidence for vitamin D as a potential treatment for fibroids, which affect millions of women worldwide.
New research highlights the importance of nurses in alleviating concerns and existential issues in newly diagnosed lung cancer patients. Nurses can provide supportive care, address death-related concerns, and help patients locate resources to manage end-of-life affairs.
A UK study provides insight into the relationship between manganese superoxide dismutase (MnSOD) and cancer progression. The research found that MnSOD expression was suppressed early in skin carcinogenesis but increased at late stages, highlighting its role as a p53-regulated gene.
Professor Mike Stratton discusses the evolution of the cancer genome at the AAAS annual meeting, highlighting advances in whole genome sequencing and the development of COSMIC catalogue. This research provides insights into cancer causation, prevention, and treatment, with potential global solutions through international collaboration.
Researchers at Polytechnique Montréal developed a new transfection method that changes the genetic material of cancer cells, allowing for precise nanometric-scale surgery. This breakthrough could lead to new therapeutic approaches in oncology, neurology, and cardiology, with promising applications.
Malnourished cancer patients who received oral nutritional support showed improvements in aspects of quality of life, including emotional functioning and loss of appetite. However, the interventions had no impact on mortality rates or consistent effects on weight gain.
A new study published in The Lancet Oncology shows that cognitive behavioural therapy (CBT) significantly reduces hot flushes and night sweats in women after breast cancer treatment. CBT improves symptoms by 46-52% compared to usual care, with sustained benefits at 26 weeks.
Researchers at Stanford University have identified a sequential treatment regimen that enhances the effectiveness of trastuzumab in xenotransplant models of breast cancer. Trastuzumab activates natural killer cells to kill HER2-overexpressing tumor cells.
Researchers have discovered a new way to enhance trastuzumab treatment in HER2-positive breast cancer patients by stimulating natural killer cells. Additionally, the activation of FoxO1 has been linked to the development of diabetic cardiomyopathy, offering a promising therapeutic target. Leptin's direct action on POMC neurons may also...
Researchers at Thomas Jefferson University found that curcumin suppresses nuclear receptor activators, which can bypass androgen deprivation therapy. Curcumin also reduced cell number and inhibited survival in prostate cancer cells, with similar results seen in mice studies.
A study published by the NIH shows that Kineret therapy is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease (NOMID). By preventing organ inflammation, scientists were able to preserve organ function in most patients.
Researchers found a gene, LTA4H, that influences inflammation to TB infection, predicting drug therapy effectiveness. This discovery suggests tailoring treatment based on patients' genetic sequences could improve patient outcomes.
Cancer tumors' metabolic profiles vary based on genes and tissue origin, necessitating individualized treatment approaches. The metabolome, in addition to the genome, is crucial for predicting metabolic changes and guiding therapy.
Researchers at LSU Health Sciences Center have identified a new protein called ARD1 that plays a critical role in the development and growth of prostate cancer. Inactivating this protein completely suppresses cancer growth, making it a potential target for new treatments.
A study published in Cancer Prevention Research found that soy isoflavone supplements did not decrease breast cancer cell proliferation. The results are consistent with previous studies on the effectiveness of dietary supplements in preventing cancer.
Glioblastoma multiforme (GBM) is a highly aggressive brain tumor resistant to current therapies. Researchers at the University of California, San Francisco, have identified PDGFR-alpha and SULF2 as potential therapeutic targets for GBM treatment. Knocking down SULF2 expression decreased cell growth in human GBM cell lines.
A study published in Science Translational Medicine found that massage reduces inflammation and promotes the growth of new mitochondria in skeletal muscle after intense exercise. The research provides evidence that massage could be a valuable treatment option for individuals with chronic inflammatory diseases or musculoskeletal injuries.